Is AIIMS Offering a Free Therapeutic Drug Monitoring Test for Epilepsy Patients?
Synopsis
AIIMS has taken a significant step to support epilepsy patients by introducing a free therapeutic drug monitoring test. This initiative ensures effective medication management without financial burden, enhancing patient care and convenience. Find out how this new service can benefit those battling epilepsy.
Key Takeaways
Free therapeutic drug monitoring for epilepsy patients.
Testing ensures safe and effective medication dosages.
Available for both inpatients and outpatients.
No external testing costs are required.
Accessible at AIIMS Delhi and AIIMS Jhajjar.
New Delhi, Jan 6 (NationPress) The All India Institute of Medical Sciences (AIIMS) has launched a complimentary therapeutic drug monitoring test specifically for individuals suffering from epilepsy, as stated by the institution.
Epilepsy is a persistent neurological condition characterized by recurrent seizures, which result from sudden, abnormal electrical activity in the brain. Symptoms may include muscle spasms, confusion, loss of consciousness, or psychological alterations.
According to AIIMS, the therapeutic drug monitoring test is designed to quantify the levels of certain medications in a patient's bloodstream. This ensures that the prescribed dosage is both safe and effective.
“Patients with epilepsy often require multiple medications. AIIMS has made the decision to provide complimentary testing for monitoring phenobarbital, carbamazepine, valproic acid, and phenytoin,” the statement elaborated.
“This drug monitoring test assesses the concentrations of these medications in the blood, allowing for an evaluation of their effectiveness and aiding in determining the correct dosage. It also identifies any potential drug toxicity,” it added.
The esteemed healthcare institution highlighted that with this new service, patients will no longer need to seek external facilities for testing, nor will they incur any fees.
Previously, patients had to pay between Rs 390 and Rs 1,880 for therapeutic drug monitoring tests at external facilities.
In a circular released on January 1, signed by Prof. Nirupam Madaan, Medical Superintendent, AIIMS instructed all departments and centers, including the National Cancer Institute (NCI), to direct patient samples to the designated laboratory for testing.
Both inpatients and outpatients are eligible for this testing service, the institute confirmed.
This service will be accessible to AIIMS Delhi OPD patients at Collection Center Room Number 3 from 8:30 AM to 1:00 PM, and also at the National Cancer Institute located at AIIMS Jhajjar.
Point of View
This initiative by AIIMS represents a significant advancement in patient care for epilepsy. By offering free therapeutic drug monitoring, the institute is demonstrating a commitment to improving healthcare accessibility and addressing the needs of vulnerable populations. It is a commendable step that aligns with the broader goal of enhancing health outcomes and ensuring that patients receive the best possible treatment without financial strain.
NationPress
20 Jun 2026
Frequently Asked Questions
What is the therapeutic drug monitoring test?
The therapeutic drug monitoring test measures the concentration of specific medications in a patient's blood to ensure safe and effective dosages.
Who can benefit from this testing service?
Both inpatients and outpatients at AIIMS can utilize this free testing service.
Where can patients access this service?
Patients can access the service at Collection Center Room Number 3 in AIIMS Delhi from 8:30 AM to 1:00 PM and also at the National Cancer Institute in AIIMS Jhajjar.
Is there any cost associated with the therapeutic drug monitoring test?
No, AIIMS is providing this test free of charge to benefit epilepsy patients.
What medications are included in the monitoring?
The test will monitor levels of phenobarbital, carbamazepine, valproic acid, and phenytoin.
